Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5EU8

Structure of FIPV main protease in complex with dual inhibitors

Summary for 5EU8
Entry DOI10.2210/pdb5eu8/pdb
Related PRD IDPRD_002214
Descriptormain protease, N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE, ZINC ION, ... (5 entities in total)
Functional Keywordsfipv, main protease, dual inhibitors, zinc, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceFeline infectious peritonitis virus (FIPV)
More
Total number of polymer chains2
Total formula weight34305.15
Authors
Wang, F.,Chen, C.,Liu, X.,Yang, K.,Xu, X.,Yang, H. (deposition date: 2015-11-18, release date: 2015-12-30, Last modification date: 2024-11-13)
Primary citationWang, F.,Chen, C.,Liu, X.,Yang, K.,Xu, X.,Yang, H.
Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors
J.Virol., 90:1910-1917, 2015
Cited by
PubMed Abstract: Coronaviruses (CoVs) can cause highly prevalent diseases in humans and animals. Feline infectious peritonitis virus (FIPV) belongs to the genus Alphacoronavirus, resulting in a lethal systemic granulomatous disease called feline infectious peritonitis (FIP), which is one of the most important fatal infectious diseases of cats worldwide. No specific vaccines or drugs have been approved to treat FIP. CoV main proteases (M(pro)s) play a pivotal role in viral transcription and replication, making them an ideal target for drug development. Here, we report the crystal structure of FIPV M(pro) in complex with dual inhibitors, a zinc ion and a Michael acceptor. The complex structure elaborates a unique mechanism of two distinct inhibitors synergizing to inactivate the protease, providing a structural basis to design novel antivirals and suggesting the potential to take advantage of zinc as an adjunct therapy against CoV-associated diseases.
PubMed: 26656689
DOI: 10.1128/JVI.02685-15
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.447 Å)
Structure validation

239149

数据于2025-07-23公开中

PDB statisticsPDBj update infoContact PDBjnumon